LPL Financial’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $40.7K | Sell |
|
|||||
|
2024
Q3 | $223K | Sell |
|
|||||
|
2024
Q2 | $129K | Buy |
|
|||||
|
2024
Q1 | $236K | Buy |
|
|||||
|
2023
Q4 | $345K | Buy |
|
|||||
|
2023
Q3 | $261K | Sell |
|
|||||
|
2023
Q2 | $602K | Buy |
|
|||||
|
2023
Q1 | $721K | Buy |
|
|||||
|
2022
Q4 | $259K | Sell |
|
|||||
|
2022
Q3 | $738K | Buy |
|
|||||
|
2022
Q2 | $184K | Buy |
|
|||||
|
2022
Q1 | $200K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $539K | Sell |
|
|||||
|
2021
Q2 | $775K | Sell |
|
|||||
|
2021
Q1 | $824K | Sell |
|
|||||
|
2020
Q4 | $878K | Sell |
|
|||||
|
2020
Q3 | $1.03M | Buy |
|
|||||
|
2020
Q2 | $969K | Buy |
|